A Dedicated Oligonucleotide Analysis System

Get information on your synthetic Oligos & Aptamers

• Molecular weight and purity of synthetic oligos and aptamers
• Quality control after synthesis or purification
• Choice of short and long gradient methods
• Ion pair mobile phases provided
  

Synthetic Oligonucleotide Therapies | Agilent

For workflow related questions, please contact Richard Blankley (Agilent) or Kamil Skirlo (ICL)